| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.24 | 7e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |